Department of Otorhinolaryngology, Head and Neck Surgery, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.
Department of Neurosurgery, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.
Otolaryngol Head Neck Surg. 2023 Jun;168(6):1502-1510. doi: 10.1002/ohn.233. Epub 2023 Jan 26.
Electrically evoked auditory brainstem response audiometry has emerged as a suitable option to intraoperatively assess cochlear nerve function during vestibular schwannoma resection. This study aimed to analyze the functional outcome and implant usage of patients with preserved auditory nerve responses after simultaneous translabyrinthine schwannoma resection and cochlear implantation.
Prospective study.
Tertiary referral center.
Patients with unilateral sporadic vestibular schwannoma underwent translabyrinthine tumor resection. Intraoperatively, electrically evoked auditory brainstem response audiometry was performed before and after tumor removal. Cochlear implantation was carried out if positive responses were detected after tumor removal indicating cochlear nerve function. Postoperatively, patients were biannually followed-up to assess aided sound field audiometry and word recognition as well as implant usage.
Overall, 26 patients with vestibular schwannoma underwent translabyrinthine schwannoma resection. Out of these patients, 15 had positive cochlear nerve responses after tumor removal and concurrently received a cochlear implant. In 13 patients with histologically confirmed vestibular schwannoma, hearing improved by 23.7 ± 33.2 decibels and word recognition by 25.0 ± 42.4% over a mean follow-up period of 18 months. Overall, 12 included patients were regular cochlear implant users.
Patients with vestibular schwannoma can benefit substantially from cochlear implantation. Intraoperative assessment of cochlear nerve function using electrically evoked auditory brainstem response audiometry can help to better identify individuals eligible for simultaneous vestibular schwannoma resection and cochlear implantation.
电诱发听觉脑干反应测听已成为一种合适的选择,可以在桥小脑角肿瘤切除术期间评估耳蜗神经功能。本研究旨在分析同时进行桥小脑角肿瘤切除和耳蜗植入术后保留听觉神经反应患者的功能结果和植入物使用情况。
前瞻性研究。
三级转诊中心。
单侧散发的前庭神经鞘瘤患者接受经迷路肿瘤切除术。术中,在肿瘤切除前后进行电诱发听觉脑干反应测听。如果在肿瘤切除后检测到阳性反应,表明耳蜗神经功能存在,则进行耳蜗植入。术后,对患者进行每半年一次的随访,以评估助听声场测听和言语识别以及植入物使用情况。
总体而言,26 例前庭神经鞘瘤患者接受了经迷路桥小脑角肿瘤切除术。其中 15 例患者在肿瘤切除后出现阳性耳蜗神经反应,并同时接受了耳蜗植入。在 13 例组织学证实为前庭神经鞘瘤的患者中,听力平均提高了 23.7±33.2 分贝,言语识别率提高了 25.0±42.4%,平均随访时间为 18 个月。总体而言,12 名纳入的患者是常规耳蜗植入物使用者。
前庭神经鞘瘤患者可以从耳蜗植入中获益匪浅。使用电诱发听觉脑干反应测听术术中评估耳蜗神经功能有助于更好地识别适合同时进行桥小脑角肿瘤切除和耳蜗植入术的患者。